BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 32,491 shares, an increase of 1,714.1% from the August 15th total of 1,791 shares. Based on an average trading volume of 25,555 shares, the short-interest ratio is currently 1.3 days.
BioPharma Credit Price Performance
BOPCF opened at $0.93 on Friday. BioPharma Credit has a 12 month low of $0.85 and a 12 month high of $1.02. The firm’s fifty day simple moving average is $0.96 and its 200 day simple moving average is $0.94.
BioPharma Credit Company Profile
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
See Also
- Five stocks we like better than BioPharma Credit
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
